Literature DB >> 1009059

Plasma cortisol suppression response in the South African black population with glaucoma.

J Freedman, R David, L A van der Walt, M H Luntz.   

Abstract

Plasma cortisol suppression was measured in 25 Black glaucomatous patients and in 19 Black patients of similar age and sex, but without glaucoma, who acted as controls. Initial serum cortisol levels were found to be slightly higher in the glaucomatous group. The response to systemically-administered cortisone was statistically more marked in the glaucomatous patients compared with the control group.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1009059      PMCID： PMC1042839          DOI： 10.1136/bjo.60.11.786

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  5 in total

1.  Suppression of plasma cortisol in normal and glaucomatous patients.

Authors:  S Rosenberg; R Levene
Journal:  Arch Ophthalmol       Date:  1974-07

2.  Plasma cortisol suppression in glaucoma.

Authors:  B Becker; S M Podos; C F Asseff; D G Cooper
Journal:  Am J Ophthalmol       Date:  1973-01       Impact factor: 5.258

3.  [Plasma cortisol and glaucoma].

Authors:  P Weinstein; E Móri
Journal:  Klin Monbl Augenheilkd       Date:  1972-09       Impact factor: 0.700

4.  Plasma cortisol differences between normal and glaucomatous patients: before and after dexamethasone suppresion.

Authors:  B Schwartz; R Z Levene
Journal:  Arch Ophthalmol       Date:  1972-04

5.  Depression of plasma cortisol and the steroid ocular pressure response.

Authors:  R Z Levene; B Schwartz
Journal:  Arch Ophthalmol       Date:  1968-10
  5 in total
  2 in total

1.  Primary open-angle glaucoma and sensitivity to corticosteroids in vitro.

Authors:  J G Sowell; R Z Levene; J Bloom; M Bernstein
Journal:  Trans Am Ophthalmol Soc       Date:  1977

Review 2.  Glucocorticoid therapy and ocular hypertension.

Authors:  Adnan Dibas; Thomas Yorio
Journal:  Eur J Pharmacol       Date:  2016-07-05       Impact factor: 4.432
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.